Agenda-Setting Tool for Children with Medical Complexity
(ASKids Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new tool, the Structured Agenda-Setting Tool, to assist in setting agendas during family meetings for hospitalized children with complex medical needs. The goal is to determine if this tool is easy to use and beneficial for families and healthcare teams. Testing occurs with families at Dartmouth Hitchcock Medical Center. Children aged 7-17 who have been hospitalized for at least four days and can speak English may qualify. As an unphased trial, this study allows families to contribute to enhancing communication tools in healthcare settings.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this agenda-setting tool is safe for children with medical complexity?
Research has shown that the Structured Agenda-Setting Tool (SAS) aims to make hospital stays less stressful and more effective for families. This tool ensures clear understanding among everyone involved in a child's care. As SAS is not a medication, it lacks the physical side effects associated with drugs.
The purpose of SAS is to enhance communication between families and medical teams during hospital meetings, leading to better understanding and coordination without the risks of new medications. Studies on similar tools have demonstrated that families and medical staff generally find them helpful and not harmful. While SAS presents no known physical safety concerns, its success relies on effective use.12345Why are researchers excited about this trial?
Researchers are excited about the Agenda-Setting Tool for children with medical complexity because it introduces a structured approach to organizing clinical visits, tailored specifically for the pediatric inpatient setting. Unlike typical care, which often lacks a formalized method for prioritizing patient needs during visits, this tool helps streamline communication and ensure that all critical issues are addressed systematically. This method aims to improve coordination and satisfaction for both families and healthcare providers, potentially enhancing the overall quality of care for these complex cases.
What evidence suggests that the Structured Agenda-Setting Tool is effective for children with medical complexity?
Research shows that structured agenda-setting tools can enhance communication between families and healthcare teams for children with complex medical needs. In this trial, participants will use a structured clinical visit agenda-setting intervention tailored for the pediatric inpatient environment. This tool ensures that important topics are addressed during meetings, improving communication. While specific data on this tool's effectiveness is limited, similar methods in organized care planning have demonstrated positive outcomes. These methods have improved care coordination and increased satisfaction for both families and healthcare providers. The goal is to ensure mutual understanding, leading to better care for the child.12346
Are You a Good Fit for This Trial?
This trial is for hospitalized children with complex medical conditions. To participate, they must be scheduled for a routine multidisciplinary family meeting at Dartmouth Hitchcock Medical Center.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of a structured clinical visit agenda-setting (SAS) intervention customized for the pediatric inpatient environment
Follow-up
Participants are monitored for feasibility and acceptability of the intervention immediately after delivery
What Are the Treatments Tested in This Trial?
Interventions
- Structured Agenda-Setting Tool
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator